Related Experiment Video
Updated: Sep 4, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Ribosomal S6 Protein Kinase 2 Aggravates the Process of Systemic Scleroderma
Mengying Jiang1, Jianan Wang2, Yingjie Shen1
1School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Abstract:
Systemic sclerosis is a complex process of pathogenesis, and the contributions of inherited genes, infections, and chemicals remain largely unknown. In this study, we showed that p90 ribosomal S6 protein kinase 2 (RSK2) was selectively upregulated in fibrotic skin and fibroblasts treated with the profibrotic cytokine TGF-β. Moreover, knockout of Rsk2 specifically in skin fibroblasts or pharmacological inhibition of RSK2 attenuated skin fibrosis in a mouse model. Mechanistically, RSK2 directly interacted with glycogen synthase kinase 3β in vivo and in vitro and thereby induced phosphorylation of glycogen synthase kinase 3β at Ser9 to inhibit ubiquitination and degradation of GLI1, which promoted fibroblast differentiation and skin fibrosis. Consequently, RSK2 plays an important role in the dermal skin of systemic sclerosis. These findings provided a potential therapeutic target for systemic sclerosis.
Related Concept Videos
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Regulation of Nuclear Protein Sorting
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

